•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08075 Summary:

BILL NOA08075C
 
SAME ASSAME AS S08991
 
SPONSORSteck
 
COSPNSRFahy, Gunther, McDonald, Novakhov, DeStefano, Simon, Davila, Bendett, Brown K, Chang, Levenberg, Weprin, Solages
 
MLTSPNSRWoerner
 
Amd §§19.09 & 25.18, Ment Hyg L; amd §3309, Pub Health L
 
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration; allows for choice of any formulation and dosage of opioid reversal agent approved by the federal food and drug administration in the purchase, distribution or authorization to prescribe or dispense such products and in any expenditure used for the purchase or distribution of an opioid reversal agent.
Go to top    

A08075 Actions:

BILL NOA08075C
 
09/27/2023referred to alcoholism and drug abuse
10/11/2023amend and recommit to alcoholism and drug abuse
10/11/2023print number 8075a
10/27/2023amend and recommit to alcoholism and drug abuse
10/27/2023print number 8075b
01/03/2024referred to alcoholism and drug abuse
01/30/2024amend (t) and recommit to alcoholism and drug abuse
01/30/2024print number 8075c
04/09/2024reported referred to ways and means
Go to top